Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

New York

Phase 2 colorectal cancer trials in New York

18 Phase 2 colorectal cancer studies are recruiting participants at sites in 14 cities across New York as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse New York by city

Cities with the most studies recruiting right now.

Every New York city with a recruiting study

New York (16), Commack (7), Harrison (6), Lake Success (3), Rockville Centre (3), Uniondale (3), Brooklyn (1), Flushing (1), Forest Hills (1), Greenlawn (1), Mount Kisco (1), Rego Park (1), Sleepy Hollow (1), Valhalla (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in New York

Basic details from each study's public record (the 12 most recently updated of 18). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    New York
    Registry record
    NCT07659795 · updated
  2. A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Commack · Harrison · New York · and 1 more U.S. location
    Registry record
    NCT05672524 · updated
  3. A Study of Retifanlimab After Chemoradiation in People With Anal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Commack · Harrison · New York · and 1 more U.S. location
    Registry record
    NCT07927998 · updated
  4. Tislelizumab in People With Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    New York
    Registry record
    NCT06529523 · updated
  5. Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Commack · Harrison · New York · and 1 more U.S. location
    Registry record
    NCT04165772 · updated
  6. A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Lake Success · New York
    Registry record
    NCT06695845 · updated
  7. Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Columbia University
    Recruiting in
    New York
    Registry record
    NCT07433673 · updated
  8. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Brooklyn · Commack · Flushing · and 10 more U.S. locations
    Registry record
    NCT05673148 · updated
  9. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Recruiting in
    New York
    Registry record
    NCT06992258 · updated
  10. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Lake Success
    Registry record
    NCT07023289 · updated
  11. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Commack
    Registry record
    NCT05489211 · updated
  12. A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Commack · Harrison · New York · and 1 more U.S. location
    Registry record
    NCT07227636 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in New York on ClinicalTrials.gov.

Ask about studies in New York

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call